
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltán Szakács, Yves Dauvilliers, V. I. Mikhaylov, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 3, pp. 200-207
Closed Access | Times Cited: 317
Zoltán Szakács, Yves Dauvilliers, V. I. Mikhaylov, et al.
The Lancet Neurology (2017) Vol. 16, Iss. 3, pp. 200-207
Closed Access | Times Cited: 317
Showing 1-25 of 317 citing articles:
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. Bassetti, Antoine Adamantidis, Denis Burdakov, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 519-539
Closed Access | Times Cited: 492
Claudio L. Bassetti, Antoine Adamantidis, Denis Burdakov, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 519-539
Closed Access | Times Cited: 492
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial
Yves Dauvilliers, Johan Verbraecken, Markku Partinen, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 201, Iss. 9, pp. 1135-1145
Open Access | Times Cited: 251
Yves Dauvilliers, Johan Verbraecken, Markku Partinen, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 201, Iss. 9, pp. 1135-1145
Open Access | Times Cited: 251
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use
Marta Kollb-Sielecka, Pierre Démolis, Joseph Emmerich, et al.
Sleep Medicine (2017) Vol. 33, pp. 125-129
Closed Access | Times Cited: 238
Marta Kollb-Sielecka, Pierre Démolis, Joseph Emmerich, et al.
Sleep Medicine (2017) Vol. 33, pp. 125-129
Closed Access | Times Cited: 238
Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
Pitolisant: A Review in Narcolepsy with or without Cataplexy
Yvette N. Lamb
CNS Drugs (2020) Vol. 34, Iss. 2, pp. 207-218
Closed Access | Times Cited: 201
Yvette N. Lamb
CNS Drugs (2020) Vol. 34, Iss. 2, pp. 207-218
Closed Access | Times Cited: 201
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Beatrice Setnik, Michael McDonnell, Catherine Mills, et al.
SLEEP (2019) Vol. 43, Iss. 4
Open Access | Times Cited: 183
Beatrice Setnik, Michael McDonnell, Catherine Mills, et al.
SLEEP (2019) Vol. 43, Iss. 4
Open Access | Times Cited: 183
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 9, pp. 2815-2830
Open Access | Times Cited: 115
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 9, pp. 2815-2830
Open Access | Times Cited: 115
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial
Yves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 303-311
Open Access | Times Cited: 94
Yves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 303-311
Open Access | Times Cited: 94
Histamine: neural circuits and new medications
Thomas E. Scammell, Alexander C. Jackson, Nicholas P. Franks, et al.
SLEEP (2018) Vol. 42, Iss. 1
Open Access | Times Cited: 109
Thomas E. Scammell, Alexander C. Jackson, Nicholas P. Franks, et al.
SLEEP (2018) Vol. 42, Iss. 1
Open Access | Times Cited: 109
Histamine receptors and cancer pharmacology: an update
N Massari, Melisa B. Nicoud, Vanina A. Medina
British Journal of Pharmacology (2018) Vol. 177, Iss. 3, pp. 516-538
Open Access | Times Cited: 101
N Massari, Melisa B. Nicoud, Vanina A. Medina
British Journal of Pharmacology (2018) Vol. 177, Iss. 3, pp. 516-538
Open Access | Times Cited: 101
The clinical spectrum of childhood narcolepsy
Emanuela Postiglione, Elena Antelmi, Fabio Pizza, et al.
Sleep Medicine Reviews (2017) Vol. 38, pp. 70-85
Closed Access | Times Cited: 100
Emanuela Postiglione, Elena Antelmi, Fabio Pizza, et al.
Sleep Medicine Reviews (2017) Vol. 38, pp. 70-85
Closed Access | Times Cited: 100
Recently Approved and Upcoming Treatments for Narcolepsy
Michael J. Thorpy
CNS Drugs (2020) Vol. 34, Iss. 1, pp. 9-27
Open Access | Times Cited: 96
Michael J. Thorpy
CNS Drugs (2020) Vol. 34, Iss. 1, pp. 9-27
Open Access | Times Cited: 96
Update on Persistent Excessive Daytime Sleepiness in OSA
Sogol Javaheri, Shahrokh Javaheri
CHEST Journal (2020) Vol. 158, Iss. 2, pp. 776-786
Closed Access | Times Cited: 91
Sogol Javaheri, Shahrokh Javaheri
CHEST Journal (2020) Vol. 158, Iss. 2, pp. 776-786
Closed Access | Times Cited: 91
Recent advances in treatment for narcolepsy
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
Lucie Barateau, Yves Dauvilliers
Therapeutic Advances in Neurological Disorders (2019) Vol. 12
Open Access | Times Cited: 84
Histamine, Neuroinflammation and Neurodevelopment: A Review
Elliott Carthy, Tommas J. Ellender
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 80
Elliott Carthy, Tommas J. Ellender
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 80
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 6
Open Access | Times Cited: 76
Claudio L. Bassetti, Ulf Kallweit, Luca Vignatelli, et al.
Journal of Sleep Research (2021) Vol. 30, Iss. 6
Open Access | Times Cited: 76
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Kiran Maski, Lynn Marie Trotti, Suresh Kotagal, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 9, pp. 1895-1945
Open Access | Times Cited: 63
Kiran Maski, Lynn Marie Trotti, Suresh Kotagal, et al.
Journal of Clinical Sleep Medicine (2021) Vol. 17, Iss. 9, pp. 1895-1945
Open Access | Times Cited: 63
Interim analysis of a post-authorization safety study of Pitolisant in treating narcolepsy: A real-world European study
Giuseppe Plazzi, Geert Mayer, Ralf Bodenschatz, et al.
Sleep Medicine (2025) Vol. 129, pp. 20-30
Closed Access | Times Cited: 1
Giuseppe Plazzi, Geert Mayer, Ralf Bodenschatz, et al.
Sleep Medicine (2025) Vol. 129, pp. 20-30
Closed Access | Times Cited: 1
Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy
Steven T. Szabo, Michael J. Thorpy, Geert Mayer, et al.
Sleep Medicine Reviews (2018) Vol. 43, pp. 23-36
Open Access | Times Cited: 72
Steven T. Szabo, Michael J. Thorpy, Geert Mayer, et al.
Sleep Medicine Reviews (2018) Vol. 43, pp. 23-36
Open Access | Times Cited: 72
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64
Reassessing the Role of Histaminergic Tuberomammillary Neurons in Arousal Control
Anne Venner, Takatoshi Mochizuki, Roberto De Luca, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 45, pp. 8929-8939
Open Access | Times Cited: 63
Anne Venner, Takatoshi Mochizuki, Roberto De Luca, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 45, pp. 8929-8939
Open Access | Times Cited: 63
Histamine H3 receptor antagonists/inverse agonists: Where do they go?
Nakisa Ghamari, Omid Zarei, José‐Antonio Arias‐Montaño, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 69-84
Closed Access | Times Cited: 60
Nakisa Ghamari, Omid Zarei, José‐Antonio Arias‐Montaño, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 69-84
Closed Access | Times Cited: 60
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP
Jean‐Louis Pépin, Ognian Georgiev, Rumen Tiholov, et al.
CHEST Journal (2020) Vol. 159, Iss. 4, pp. 1598-1609
Open Access | Times Cited: 58
Jean‐Louis Pépin, Ognian Georgiev, Rumen Tiholov, et al.
CHEST Journal (2020) Vol. 159, Iss. 4, pp. 1598-1609
Open Access | Times Cited: 58
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 46
María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 46
Narcolepsy
Lucie Barateau, Fabio Pizza, Giuseppe Plazzi, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 35
Lucie Barateau, Fabio Pizza, Giuseppe Plazzi, et al.
Journal of Sleep Research (2022) Vol. 31, Iss. 4
Closed Access | Times Cited: 35